Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Teaching-Focussed Lecturer in Life Sciences on the Integrated Foundation Year (IFY) Programme at Royal Holloway, University of London. This is a 0.4 FTE position. The well-established and successful IFY
-
Scheme and support the administration of various financial awards including QM Prizes, Scholarships, the Expedition Fund, the Cambridge Long Vacation Scheme and the US Loans Programme. The post will
-
About the Role We employ Portfolio, Programme and Project Management best practice principles using the industry standard MoP, PRINCE2 and MSP methodologies; however this is a pragmatic
-
to improve people's health in developing countries by striving for excellence in research, healthcare, and training. Our research program spans basic scientific research, clinical studies, epidemiological
-
to the expansion and diversification of the London-based experiential programme portfolios. The core components of this portfolio are known as the London Business Challenge Week, LondonCAP and LondonLAB programmes
-
Dubai to join Degree Education in Dubai on a permanent basis. The Senior Admissions Manager for the EMBA Dubai programme is responsible for leading the admissions processes to achieve the programme's
-
, Asylum and Nationality Act 2006. Full-Time, Permanent The Role The CoSTARNational R&D Lab, led by Royal Holloway, University of London, is seeking a strategic, driven, and collaborative Head of Programme
-
Programme Admin Officer in the School of Life Sciences & the Environment. The School consists of five departments: Biological Sciences, Earth Sciences, Geography, Health Studies and Psychology. It is
-
-holder will be a member of the department administration team and be accountable to the ANH Platform Programme and Grants Funding Manager and the Principal Investigator. The post-holder will also be
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing